Michael Gutch - 24 Jun 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
ALBO
Transactions as of
24 Jun 2022
Transactions value $
$0
Form type
4
Filing time
28 Jun 2022, 16:01:28 UTC
Previous filing
19 Jan 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALBO Stock Option (right to buy) Award $0 +8,000 $0 8,000 24 Jun 2022 Common Stock 8,000 $19.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest and become exercisable in full on the earlier of (i) June 24, 2023 or (ii) the day prior to the issuer's 2023 annual meeting of stockholders, subject to the director's continued service on the issuer's board of directors on the vesting date.